April 20, 2026 03:03 am (IST)
Follow us:
Migraine treatment injection from Dr Reddy's Lab now available in the US
Hyderabad/Princeton-NJ, Apr 19 (IBNS) Promius Pharma LLC, a subsidiary of Dr. Reddy's Laboratories Ltd, has informed on Tuesday that its ZEMBRACE SymTouch (sumatriptan injection) 3 mg, which was approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.
The company said that ZEMBRACE SymTouch is a pre filled, low-dose, ready-to-use, 2-step autoinjector containing 3 mg of sumatriptan, a selective 5-HT1B/ID receptor agonist. Because ZEMBRACE SymTouch is a subcutaneous injection, it may lead to rapid relief of migraine.
Migraineurs often have more than one kind of attack. Different types of medications can be used to treat different types of attacks.
According to Roger Cady, MD, Associate Executive Chairman of the National Headache Foundation “ZEMBRACE SymTouch is a welcome addition to the toolkit for acute treatment of migraine. This 3-mg, easy to-use subcutaneous injection of sumatriptan may be desired by many migraine patients who need a medication that can rapidly treat migraine attacks. Also, the 3-mg dose allows for up to 4 doses of ZEMBRACE SymTouch in a 24-hour period, thus allowing dosing flexibility for patients.”
ZEMBRACE SymTouch is available as a box of 4 autoinjectors.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
From minerals to microchips: Odisha’s big leap into future tech
Sun, Apr 19 2026
Game changer: India’s first Advanced 3D Glass Semiconductor Packaging Unit to be unveiled in Odisha
Sat, Apr 18 2026
Meta eyes first wave of layoffs on May 20: Report
Sat, Apr 18 2026
Adani Group shares rise as Gautam Adani becomes Asia’s richest, overtakes Mukesh Ambani
Fri, Apr 17 2026
Lenskart dress code row: Hijab allowed, bindi restriction triggers backlash; CEO responds
Thu, Apr 16 2026
Rupee rises 9 paise, upside limited by dollar demand
Thu, Apr 16 2026
Sensex, Nifty rise as oil slips on West Asia de-escalation hopes
Thu, Apr 16 2026